Symbol="PRTK"
AssetType="Common Stock"
Name="Paratek Pharmaceuticals Inc"
Description="Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other threats to public health for civil, government and military use. The company is headquartered in Boston, Massachusetts."
CIK="1178711"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="75 PARK PLAZA, 4TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="125162000"
EBITDA="-47908000"
PERatio="None"
PEGRatio="-0.02"
BookValue="-3.3"
DividendPerShare="0"
DividendYield="0"
EPS="-1.17"
RevenuePerShareTTM="2.998"
ProfitMargin="-0.395"
OperatingMarginTTM="-0.29"
ReturnOnAssetsTTM="-0.188"
ReturnOnEquityTTM="0"
RevenueTTM="166643000"
GrossProfitTTM="99389000"
DilutedEPSTTM="-1.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.256"
AnalystTargetPrice="3.1"
TrailingPE="-"
ForwardPE="1.721"
PriceToSalesRatioTTM="0.856"
PriceToBookRatio="-"
EVToRevenue="2.868"
EVToEBITDA="-4.426"
Beta="1.709"
num_52WeekHigh="3.65"
num_52WeekLow="1.29"
num_50DayMovingAverage="1.956"
num_200DayMovingAverage="2.191"
SharesOutstanding="57282000"
DividendDate="2014-10-29"
ExDividendDate="2014-10-31"
symbol="PRTK"
open="2.19"
high="2.21"
low="2.19"
price="2.20"
volume="217956.00"
latest_trading_day="2023-07-13"
previous_close="2.20"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="33"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="67"
Volume_recent_avg="917018"
Change_recent_avg="0.01"
Delta_recent_avg="0.13"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.37"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="67"
Aroon_momentum_negative="33"
image_negative_thumbnail_id_1="99"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0077.jpeg"
image_negative_thumbnail_id_2="147"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0029.jpeg"
image_neutral_thumbnail_id_1="565"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="975"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_positive_thumbnail_id_2="635"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0073.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
